Communicating Multiple Uncertainties Associated With the Benefits and Risks of New Cancer Drugs

NCT07110597 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

3184

Enrollment

OTHER

Sponsor class

Conditions

Cancer

Interventions

OTHER: Statement communicating 1 source of uncertainty
OTHER: Statements communicating 2 sources of uncertainties
OTHER: Statements communicating 3 sources of uncertainties
OTHER: Statements communicating 4 sources of uncertainties
OTHER: Control group

Sponsor

London School of Economics and Political Science

Collaborators

[object Object]